Hospitals must not deny Ivermectin and Hydroxychloroquine to anyone any longer.
Dan Ball hosts Real America, I cite the 2 most successful comparative US inpatient studies. Patients denied medication reconciliation and shared decision making. Oral generics started early much safer and more effective approach than financially incentivized Remdesivir.
The Dangers Of Remdesivir
Dan Ball on Remdesivir pointing out mixed data and overall meta-analysis by WHO Solidarity May ’22 showing neutrality. So AKI or DILI tip the balance against use as per WHO Nov ’20 advisory. DHHS bonus for US hospital use perversely incentivized use which hurt some Americans.